Key facts
- Tandem (Healthcare Technology Systems)’s last known valuation is $950.0M (Jan 2026).
- It has raised $137.4M; the latest was Early Stage VC ($100.0M) in Jan 2026.
- Notable investors include General Catalyst, SOSV, Accel, BoxGroup, Bain Capital Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Tandem (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Tandem (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tandem (Healthcare Technology Systems)
Developer of a prescription wallet designed to provide medicine at an affordable price. The company's platform allows doctors to send prescriptions and check insurance coverage, coupons, and prices across pharmacies, enabling patients to get medicines quickly and at a low price and doctors to treat their patients consistently.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 39
- Website
- withtandem.com/
- Ownership
- Privately Held (backing)
Tandem (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tandem (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tandem (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.